Tumor working group | Number of patients | Participation rate 2017–2018 |
---|---|---|
Gynecological oncology | 910 | 94% |
Lung oncology | 831 | 64% |
Testicular oncology | 98 | 100% |
Head and neck oncology | 1319 | 64% |
Medical oncology/immunotherapy | 77 | a |
Hematological oncology | 343 | a |
Neuro-endocrine oncology | 45 | a |
Bone and soft-tissue oncology | 36 | a |
Hereditary breast-ovarian cancer | 45 | a |
Total | 3704 |